« Previous
Next »
Journal of Voice
Volume 25, Issue 1
, Pages 114-119
, January 2011
Interarytenoid Muscle Botox Injection for Treatment of Adductor Spasmodic Dysphonia With Vocal Tremor
References
- . Botulinum Toxin Management of Spasmodic Dysphonia: a 12-year experience in more than 900 patients. Laryngoscope. 1998;108:1435–1441
- . Contemporary management of spasmodic dysphonia. Curr Opin Otolaryngol Head Neck Surg. 2004;12:543–548
- . Common movement disorders affecting the larynx: a report from the neurolaryngology committee of the AAO-HNS. Otolaryngol Head Neck Surg. 2005;133:654–665
- . Analysis of factors affecting botulinum toxin results in spasmodic dysphonia. J Voice. 1996;10:306–313
- . Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography. Ann Otol Rhinol Laryngol. 2004;113:602–612
- . An evaluation of laryngeal muscle activation in patients with voice tremor. Otolaryngol Head Neck Surg. 1992;107:684–696
- . The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report. J Voice. 2000;14:410–421
- . Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection. Laryngoscope. 2000;110:1366–1374
- . The study of laryngeal muscle activity in normal human subjects and in patients with laryngeal dystonia using multiple fine-wire electromyography. Laryngoscope. 2001;111(suppl 97):1–47
PII: S0892-1997(09)00121-0
doi: 10.1016/j.jvoice.2009.08.003
© 2011 The Voice Foundation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Voice
Volume 25, Issue 1
, Pages 114-119
, January 2011
